Dataset Information

Bbubalis - Seminal fluid, iBAQ (Britoetal,reproddomestanim2018)

ABSTRACT: abundance based on iBAQ, Interaction consistency score: 0.8, Coverage: 1

ORGANISM(S): 89462

SUBMITTER: Christian von Mering

PROVIDER: 2599551988 | PAXDB | 2018

REPOSITORIES: PAXDB

ACCESS DATA

Dataset's files

Source:

			Action	DRS
	bioprojects-abundance-files-v4.0.zip	Other

Items per page:

1 - 1 of 1

Publications

Label-free proteome of water buffalo (Bubalus bubalis) seminal plasma.

Brito Mayara F MF Auler Patrícia A PA Tavares Guilherme C GC Rezende Cristiana P CP Almeida Gabriel M F GMF Pereira Felipe L FL Leal Carlos A G CAG Moura Arlindo de Alencar AA Figueiredo Henrique C P HCP Henry Marc M

Reproduction in domestic animals = Zuchthygiene 20180611 5

The study aimed to describe the Bubalus bubalis seminal plasma proteome using a label-free shotgun UDMS<sup>E</sup> approach. A total of 859 nonredundant proteins were identified across five biological replicates with stringent identification. Proteins specifically related to sperm maturation and protection, capacitation, fertilization and metabolic activity were detected in the buffalo seminal fluid. In conclusion, we provide a comprehensive proteomic profile of buffalo seminal plasma, which es ...[more]

PMID: 29888513

Similar Datasets

Project description:Less than 30% of children with high-risk (HR) metastatic neuroblastoma (NB) show a long survival (Pearson 2000). In order to identify novel molecular prognostic markers useful to better predict patientsM-bM-^@M-^Y relapse risk estimation, we performed genome- and/or transcriptome-wide analyses of 129 stage 4 HR-NBs. This is the largest study for this NB subtype. Children older than 1 year of age at diagnosis were categorized as M-bM-^@M-^\short-survivorsM-bM-^@M-^] (dead of disease within 5 years from diagnosis) and M-bM-^@M-^\long-survivorsM-bM-^@M-^] (alive with an overall survival time > 5 years). A significant correlation of patient survival with the presence of small number of segmental copy number aberrations (CNA < 3) was observed. Thus, within the group of stage 4 HR-NBs, we identified a specific subgroup of patients (those with highest number of CNA) that have a higher risk of progression/recurrence. The complex genomic pattern is an independent prognostic marker, since MYCN oncogene amplification only affects the predictive value of single CNA (i.e., 1p loss, 17q gain). Integrative analysis of genomic and expression signatures demonstrated that fatal outcome is associated with loss of cell cycle control and with progression of tumor due to deregulation of Rho GTPase signaling and genes related to cell motility. Tumors with MYCN amplification showed a lower chromosome instability compared to MYCN-single copy NBs (P=0.0008), dominated by 17q gain and 1p loss. Moreover, our results suggest that the MYCN amplification mainly drives the disruption of neuronal differentiation and the reduction of cell adhesion process involved in tumor invasion and metastasis. For array-CGH profiling, we analyzed 91 samples of metastatic neuroblastomas. All patients were classified as stage 4 and they were older than 1 year of age at time of diagnosis. Regarding the clinical course, 46 were short-survivors (dead of disease within 60 months from diagnosis. Deaths due to toxicity were censored) and 45 were long-survivors (alive with an overall survival time > 60 months). This submission consists of 22 new samples and 69 other cases previously deposited in GEO under Series accessions GSE14109 and GSE25771.